The Therapeutic Approaches for Hepatitis C Virus: Protease Inhibitors and Polymerase Inhibitors
Author:
Publisher
The Editorial Office of Gut and Liver
Subject
Gastroenterology,Hepatology
Link
http://pdf.medrang.co.kr/GNL/2011/005/gnl-5-406.pdf
Reference46 articles.
1. Hepatitis C Virus Infection
2. Replication of hepatitis C virus
3. Short-term antiviral efficacy of BILN 2061, a hepatitis C virus serine protease inhibitor, in hepatitis C genotype 1 patients
4. Antiviral activity of telaprevir (VX-950) and peginterferon alfa-2a in patients with hepatitis C
5. Telaprevir, peginterferon alfa-2a, and ribavirin for 28 days in chronic hepatitis C patients
Cited by 27 articles. 订阅此论文施引文献 订阅此论文施引文献,注册后可以免费订阅5篇论文的施引文献,订阅后可以查看论文全部施引文献
1. Structural similarities between SARS-CoV2 3CLpro and other viral proteases suggest potential lead molecules for developing broad spectrum antivirals;Frontiers in Chemistry;2022-10-06
2. HCV NS5B RdRp mutations and their effects on ligand binding affinity;International Journal of Modelling and Simulation;2021-05-24
3. Viral Hepatitis C Therapy: Pharmacokinetic and Pharmacodynamic Considerations: A 2019 Update;Clinical Pharmacokinetics;2019-05-21
4. High SVR12 with 8-week and 12-week glecaprevir/pibrentasvir therapy: An integrated analysis of HCV genotype 1–6 patients without cirrhosis;Journal of Hepatology;2018-08
5. Efficacy and Safety of Glecaprevir/Pibrentasvir in Patients Coinfected With Hepatitis C Virus and Human Immunodeficiency Virus Type 1: The EXPEDITION-2 Study;Clinical Infectious Diseases;2018-03-16
1.学者识别学者识别
2.学术分析学术分析
3.人才评估人才评估
"同舟云学术"是以全球学者为主线,采集、加工和组织学术论文而形成的新型学术文献查询和分析系统,可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容,当前同舟云学术共收录了国内外主流学术期刊6万余种,收集的期刊论文及会议论文总量共计约1.5亿篇,并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询!咨询电话:010-8811{复制后删除}0370
www.globalauthorid.com
TOP
Copyright © 2019-2024 北京同舟云网络信息技术有限公司 京公网安备11010802033243号 京ICP备18003416号-3